Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients

S. E. Ettinghausen, J. G. Moore, D. E. White, L. Platanias, N. S. Young, S. A. Rosenberg

Research output: Contribution to journalArticlepeer-review

145 Scopus citations

Fingerprint

Dive into the research topics of 'Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds